Aspargo Laboratories, Inc

Aspargo Laboratories, Inc. is a clinical-stage biopharmaceutical company developing patient-focused solutions and must-have medicines by combining our innovative science and technologies and FDAs 505(b)(2) approval pathway to enhance currently marketed drugs with well-known pharmacology profiles. Our company was formed for the purpose of commercializing innovative therapies qualifying for FDA approval under the section 505 b(2) regulatory approval pathway for new formulations of previously approved drugs. The companys initial product candidate is a proprietary oral suspension spray formulation of sildenafil citrate, the active ingredient in VIAGRA. Our mission is to develop patient-focused solutions and must-have medicines by applying our innovative science...

Aspargo laboratories, inc operates in the Biotechnology research industry.

Aspargo laboratories, inc's revenue is 11m - 100m

Aspargo laboratories, inc has 11 - 50 employees.